Organophosphorus compounds (OPs) were developed as chemical weapons before World War II. OPs have been widely used as insecticides in agriculture because of their effectivenss in killing insects. They remain in a relatively small amount in the environment compared with halogenide 1) . Meanwhile, OPs have been largely used not only as intermediaries in organic syntheses, but also as plasticizers and anti-oxidants in synthetic resins in the polymer industry 2) . OPs poisoning occurs mainly as a result of accidental ingestion or exposure in the processes producing organophosphorus compounds or spraying organophosphorus insecticides 3) . OPs induce acute toxicity by inhibiting acetylcholinesterase. Some OPs also produce organophosphorus compound-induced delayed neurotoxicity (OPIDN) in humans and certain animal species (e.g., chickens, cats, dogs and farm animals) one week or more after exposure 2, 4, 5) . These OPs include leptophos, tri-o-cresyl phosphate (TOCP), diisopropylfluorophosphate (DFP), ethyl para-nitrophenyl (EPN), trichlorfon, dichlorvos, fenthion, isofenphos and chlorpyrifos 2, 3, 5) . The clinical signs of OPIDN are characterized by a delay period followed by ataxia which may progress to paralysis 1) . Histopathologic changes consist of Wallerian-type degeneration of the longest and largest diameter axon and myelin of the central and peripheral nervous systems [6] [7] [8] [9] . Clinical, electrophysiological and nerve biopsy data revealed a 6 and B 12 on organophosphorus compound-induced delayed neurotoxicity (OPIDN) caused by leptophos and tri-ocresyl phosphate (TOCP) as organophosphates (OPs) were examined. Nine groups of hens (six for each) were used. Eight groups received intravenous injection of 30 mg/kg of leptophos or 40 mg/kg of TOCP (four groups in each). Among them, three groups which received leptophos were given (p.o.) predonisolone (2 mg/body), vitamin B complex (25 mg/body) or both 3 h after OPs injection and then every day for 15 d (one group for each); the same treatment was performed on three groups which received TOCP. The remaining one group served as controls. It was observed that delayed neuropathy induced by OPs could not be resisted completely by the treatment with prednisolone or vitamin B complex, but clinical signs of OPIDN and pathological changes in hens that received these two protective agents after OPs were less severe than those in hens that received only OPs. Of these groups, the improvement in clinical signs was best shown in hens that received the both two protective agents. In addition, improvement in clinical signs among the hens that did not deteriorate to paralysis was observed. In particular, those which developed mild ataxia recovered well. It is indicated that combining administration of prednisolone and vitamin B complex early before clinical signs are manifest is effective in alleviating neuropathy 7) . The acute toxic signs induced by these OPs are usually amenable to treatment with atropine and pyridine 2-aldoxime 10, 11) . By contrast, because there is no effective cure, prognoses of most patients with delayed neurotoxic signs are poor and serious sequelae remain [12] [13] [14] . Abou-Donia et al. 15) reported that progression or improvement of symptoms of OPIDN or recovery depended on the dose and duration of exposure to these OPs; constant exposure to large daily doses led to ataxia, paralysis and death.
One of the major functions of synthetic adrenal cortical hormone is anti-inflammation 16) . The B vitamins such as vitamin B 1 , B 2 , B 6 and B 12 help to maintain the health of the nerves, proper brain function and energy metabolism 17) . In clinical settings, synthetic adrenal cortical hormone and vitamin B complex are often used in therapy of neuritis or polyneuropathy 18, 19) , but the effects of these medicines on OPIDN are unclear, a l t h o u g h e v i d e n c e h a s b e e n s h o w n t h a t methylpredonisolone prevents OPIDN in cats given DFP 20) . Since patients who suffer from polyneuropathy come to a hospital after clinical signs are manifest, these medicines have to be administered when the disease is in progress. In the case of OPIDN, it might have been essential to administer the protective agents before clinical signs are manifest or when neuropathy is less severe 21, 22) . The purpose of the present study is to examine the protective effects of prednisolone as a synthetic adrenal cortical hormone 24) and the complex of vitamin B 1 , B 2 , B 6 and B 12 23) against OPIDN induced by leptophos and TOCP when the two protective agents are administered before the onset of OPIDN.
Materials and Methods

Chemicals
Crystallized leptophos was prepared from emulsifiable concentrate (Phosvel ® , Nippon Noyaku Co., Tokyo Japan), containing 34% active leptophos, by a procedure described previously 25) . The purity of the crystals was found to be 96% or more by gas chromatography. TOCP (purity>99%) was purchased from Eastman Kodak (New York, USA). The solutions of leptophos and TOCP were prepared just before each administration by dissolving in glycerol formal. Glycerol was purchased from Aldrich Chemical Co. (Milwaukee, USA). Predonine ® (Sioyagi Seyaku Co., Osaka, Japan), containing 100% of prednisolone as an effective ingredient, and Neurovitan ® (Fujisawa Yakuhin Co., Osaka Japan), which contains vitamin B 1 , B 2 , B 6 and B 12 , 100, 10, 160 and 1 mg, respectively, in 1 g of the complex, were used as agents protecting against OPIDN.
Animals and administration
Fifty-four adult laying hens (Gallus gallus domesticus), twenty months of age, were used. At the start of the experiment, the weight of the animals was 1.8-2.2 kg. After one week of observation, confirming no abnormal signs, the hens were caged individually in an airconditioned (20°C) room with a 12-h light-dark cycle. Food and water were allowed ad libitum. The hens were randomly divided into 9 groups as shown in Table 1 . Two groups received leptophos or TOCP alone, respectively. Six groups were given leptophos or TOCP, followed by prednisolone and/or vitamin B complex for 15 d. One 
Assessment of delayed neurotoxicity
The progress of clinical signs of OPIDN was evaluated by a 7-point scale 5) as follows: 1) normal (0 point), no defects in posture and working performance; 2) suspected ataxia (1 point), the bird appeared to lack strength in the legs and tottered; 3) mild ataxia (2 points), the bird was slow, clumsy and had an unsteady gait; 4) gross ataxia (3 points), the gait was always abnormal with waddling, although the bird was still active, it would often stagger and fall; 5) mild paralysis (4 points), typical paralytic posture and the appearance of leg drop; 6) severe paralysis (5 points), the bird was unable to maintain its posture, to stand up, or to move at all; and 7) death due to muscular paralysis of the respiratory organs (6 points).
Histopathology
Two hens, which manifested the severest clinical signs, were chosen in each experimental group for pathological observation for 60 d after OPs dosing. Of the controls, two hens were also chosen at random. These hens were deeply anesthetized with pentobarbitone, the thoraxes were opened and the tissues fixative (buffered glutaraldehyde, pH 7.4) inserted via a needle into the left ventricle of the heart 7) . Perfusion by means of a gravityfeed system with a pressure head of 1 m was continued for a period of 5-10 min until all muscles became rigid (volume of 200-300 ml fixative). The spinal cord was carefully dissected from the spinal column without kinking, after the dura had been incised, it was suspended in fixative. The fixed cord was divided into three equal parts as follow: the cervical region, the thoracic region and the lumbosacral region. The segments were dehydrated and sampled into transverse blocks. These blocks were routinely processed and embedded in paraffin wax, sectioned at 10 µm, and stained with hematoxylin and eosin. Transverse sections were examined microscopically.
Statistical analysis
Differences in OPIDN scores between groups were examined by the Kruskal-Wallis test and the MannWhitney U test with the Stat View version 5.0 (SAS Institute Inc., USA). Two-way analysis of variance of OPIDN scores was performed with OPs (leptophos vs TOCP) and protective agents (with vs without these agents) as factors to examine their effects on scores separately with their interactions with the SPSS version 11.0 (SPSS Inc, Japan). Table 1 . The control group (Group 1) did not manifest clinical signs of OPIDN. Clinical signs of OPIDN were observed in all groups of hens which received OPs; there were significant differences in OPIDN scores between controls and the remaining groups (Group 2-9). OPIDN scores were lower in hens given prednisolone and/or vitamin B complex after OPs administration (Groups 3-5, 7-9) than in those which received OPs alone. Especially the OPIDN scores in groups which received vitamin B complex or both prednisolone and vitamin B complex after leptophos administration (Groups 3-5) were significantly lower than the group given only leptophos (Group 2). Kruskal-Wallis test showed that OPIDN scores significantly varied among Groups 1-5 and Groups 1, 6-9, respectively (H=11.9 and 9.6, p<0.05).
Results
OPIDN scores in each group are shown in
Results of the two-way analysis are shown in Table 2 . Differences in OPIDN scores between the groups of animals with and without protective agents were significant for vitamin B complex, predonisolone or both. By contrast, the differences between the two OPs used here were not significant. Interactions between protective agents and OPs were not significant.
Histopathology of the lumbar spinal cord from controls, leptophos alone, prednisolone and/or vitamin B complex after leptophos administration on the 30th day is shown in Fig. 1 . Degeneration of spinal neurons in the dorsal columns was observed in the hens that received leptophos alone. Moreover, swollen axons, disrupted myelin, digestive chamber, complete axonal degeneration, and scars due to hyperplasia of glia cells as a substitute for necrotic nerve fibers were also observed in the same group, whereas specimens from the hens that received prednisolone and vitamin B complex after leptophos administration showed mild myelin disruption. No pathological changes in neurons and axons were observed in the controls. Histopathological changes in the lumbar spinal cord in hens exposed OPs were alleviated by prednisolone or vitamin B complex alone, but no significant difference between the effects of prednisolone Table 3 . The hens which showed mild paralysis (4 points) 30 d after OPs administration deteriorated further to the 60th day and led to death. Those with mild ataxia (2 points) or gross ataxia (3 points) on the 30th day manifested improvement by 60 d later. Among the animals with mild ataxia, complete recovery was also observed.
Discussion
Although clinical signs of OPIDN were observed in all hens which received OPs, signs and pathological changes in the hens that received prednisolone and/or vitamin B complex after OPs administration were less severe than those which received only OPs. Histopathological examination of nervous tissue in OPIDN showed axonal swelling, axonal debris, digestive chambers and myelophages in the hens exposed to neuropathic OPs 7) , suggesting that inflammatory response was involved in the progression of OPIDN. Baker and S t a n e c 2 0 ) r e p o r t e d t h a t a d m i n i s t r a t i o n o f methylpredonisolone 30 to 40 min after DFP prevented OPIDN. This is in accordance with our findings. It is therefore suggested that prednisolone can inhibit progression of neuropathy and alleviate clinical signs of OPIDN associated with an anti-inflammatory action.
In the present study, we also observed a protective effect of vitamin B complex on OPIDN. The B vitamins play important roles in maintaining the health of nerves and proper brain function 17) . They also act as coenzymes, helping enzymes to react chemically with other substances, and are involved in energy production 17) . The observation of protective effects of vitamin B complex may be associated with nourishing and regenerating actions of vitamin B complex and maintaining homeostasis in the nervous tissue. In addition, improvement of clinical signs in hens which received both prednisolone and vitamin B complex early before the onset of OPIDN was the best, as paralysis in this group did not emerge excepting in one hen. It is indicated that combined administration of prednisolone and vitamin B complex is more effective in alleviating neuropathy than administration of either of the two agents alone. The present study, together with those by Baker and Stanec's 20) and us 22) , suggest that early administration is the key to alleviating neuropathy. Otherwise, prednisolone and vitamin B complex may not be effective in recovering the function of nerves and muscles affected by neuropathy.
Although it was reported that the mechanism of OPIDN is related to specific inhibition of a particular protein known as neuropathy target esterase (NTE), and a subsequent molecular rearrangement called 'aging' 26, 27) , the pathogenesis of OPIDN is still unclear, so that it is difficult to develop preventive measures or a cure based on the pathogenesis of OPIDN. Our findings, however, suggest that, when an acute poisoning caused by neuropathic OPs is treated, the use of predonisolone or (2) +++ (1), Death (1) ++++ (1) Death (1) OPs and prednisolone + vitamin B complex (Groups 5 + 9) + (4) -(1), + (2), +++ (1) ++ (2) + (2) a : -= no clinical signs; +~++++ = OPIDN scores of 1-4; death=OPIDN scores of 6. b : Number of hens in parenthesis.
vitamin B complex to treat delayed neuropathy should be considered. It is also necessary to further explore the molecular mechanism under the preventive effects of prednisolone and vitamin B complex against OPIDN. Finally, because of the small number of animals, we did not conduct an analysis for multiple comparisons.
Multiple significance tests with large number of animals should be necessary.
